Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
NCT06201676Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac in post-traumatic pain, opioid use disorder (OUD), sponsored by Massachusetts General Hospital. Started Feb 2025; status: recruiting.
02
Drugs
ketorolac
03
Conditions
post-traumatic painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06201676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06201676.